How a Buyer Verified a Medical Device Supplier’s Legitimacy and Regulatory Readiness
A buyer evaluating a medical device supplier needed to confirm company legitimacy, export activity, and regulatory readiness before moving forward. SourcingX helped by reviewing public company information, trade signals, and due diligence notes to highlight what was confirmed and what still needed verification.
The Buyer’s Request
A buyer requested a thorough background investigation for a named medical device supplier, with an added need to generate an RFQ and document checklist for regulated medical devices. The goal was to understand whether the supplier appeared to be a legitimate, export-active manufacturer and what documents or confirmations should be requested before proceeding.
What SourcingX Analyzed
- Company registration and operating history
- Registered capital and staffing scale
- Export shipment activity over the last two years
- Public company presence and business consistency
- Legal and administrative risk signals
- RFQ and document checklist requirements for regulated devices
Key Findings
The following findings were identified from the data reviewed for this sourcing task.
The supplier appears to be a real, long-established manufacturer
Public registry information in the due diligence report indicates the company was established in 1999 and has operated for more than 27 years.
Why it matters: A long operating history can support basic legitimacy screening and reduce the risk of engaging a newly formed or shell entity.
Note: This confirms longevity, but it does not by itself verify factory ownership, current production capacity, or product-level authorization.
Scale signals are consistent with a large enterprise
The report states registered capital of 1.212 billion RMB and staffing in the 5,000–9,999 range, which is consistent with a major industrial manufacturer.
Why it matters: Large-scale registry signals can help a buyer assess whether the supplier is [REDACTED_ORDER_OR_CONTRACT_NUMBER] for institutional or regulated medical device procurement.
Note: These are public registry signals; they should still be cross-checked against the exact legal manufacturing entity and current operational status.
Export activity is strong and recent
Trade records show 4,997 shipments over the last two years, with the latest shipment dated 2026-04-13.
Why it matters: Recent and repeated shipment activity suggests active commercial operations and provides a basis for deeper export record verification.
Note: Export records do not confirm that every shipment matches the exact product model or market the buyer wants to source.
Public business signals are broadly consistent
The report notes the presence of a corporate website, ICP registration, landline, and corporate email, and describes these signals as consistent with a formal business setup.
Why it matters: Consistent public business information can support company verification and reduce ambiguity during initial supplier screening.
Note: The source trace does not confirm on-site factory verification, authorized distribution status, or whether all contact channels are currently monitored.
The main risk is product-level compliance and accountability
The report and agent summary say the key caution is not basic existence, but model-level regulatory validity, channel authority, after-sales responsibility, and traceability.
Why it matters: For regulated medical devices, a supplier can be real yet still fail buyer requirements if the exact models, registrations, or service obligations are not verified.
Note: The trace mentions legal and administrative records, but it does not provide a complete legal risk file in the visible evidence.
Have a similar sourcing task?
Run the same kind of analysis on your own product in SourcingX Chat.
How This Helped the Buyer
- Separated basic company legitimacy from product-level compliance risk
- Highlighted export activity that supports further verification
- Identified the need to confirm exact legal entity, registrations, and service obligations
- Provided an RFQ/document checklist structure for regulated medical devices
Data Reviewed and Notes
Data reviewed
- Buyer request and follow-up context for a supplier due diligence task
- Due diligence report summary and written report file
- Trade record output showing shipment counts, values, and latest shipment date
- Dashboard artifact generated from the due diligence report
- RFQ and document checklist report for regulated medical devices
Limits to keep in mind
- The visible evidence does not fully confirm factory ownership or on-site verification
- Legal and administrative records are mentioned in summary form, but the full case file is not visible here
- Product-specific registrations and authorized channel status were recommended for verification, not fully proven in the trace
- The target market was not specified in the source trace
Recommended Next Steps
Based on the available findings, the buyer could consider the following actions:
- Confirm the exact legal manufacturing entity and match it to the quoted product models
- Request product-specific registrations, certificates, and market authorization documents
- Ask for a written after-sales, warranty, and traceability responsibility statement
- Verify factory address, ownership, and operational status through an on-site or video audit
- Cross-check recent export records against the exact models and destination market
- Use the RFQ checklist to request model-specific pricing, lead time, and compliance documents